In a recent article, we discussed how courts have used patent specifications in finding that patents satisfy the Supreme Court’s Mayo/Alice test. However, the specification may be a double-edged sword ...

Broad chemical genus claims often represent some of the most valuable assets in a pharmaceutical or chemical patent portfolio. By covering ...

The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...

After Amgen the Supreme Court made what some believe to be significant changes to the law of enablement, finding that the 26 examples, 400+ pages of disclosure and information submitted on via CD ROM ...

“Though these new guidelines may seem unnecessary, there is clear benefit to the public, especially to the applicants who rely on patents for future innovative endeavors.” The United States Patent and ...

A med tech case decided by the PTAB is helpful to inform patent strategy for AI enabled inventions across various disciplines and industries. Patent applicants should expect to see reliance by the ...